Waverley Pharma Inc V.WAVE

Healthcare Biotechnology

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution agreement with Reliance Life Sciences Private Limited, which has granted it an exclusive territorial license to market and sell capecitabine in the UK and Germany as well as a non-exclusive territorial license to market and sell temozolomide and erlotinib in the UK. Its generic oncology products include bortezomib and pemetrexed. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma.

TSXV:WAVE - Post by User

Waverley Pharma Inc > Waverley Pharma Announces Tentative ANDA Approval for Pemetr

<< Previous

Bullboard Posts

Next >>

Comment by pinkfloyd90on Nov 23, 2020 2:18pm

130 Views

Post# 31953912

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Waverley Pharma Announces Tentative ANDA Approval for Pemetr

if jerico sold...the stock would go to 3 cents. his small team owns a couple of mill....you would be fortunate if the stock went down to 3 cents...because a major nr would bring this way back up....pharma stocks take time...alot of time...TIME.....dark side of the moon....1974.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec